Diploma PLC (LON:DPLM - Get Free Report) shares crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 4,299.31 ($59.00) and traded as high as GBX 4,904 ($67.30). Diploma shares last traded at GBX 4,868 ($66.80), with a volume of 407,228 shares.
Diploma Trading Up 1.6%
The company has a 50 day moving average of GBX 4,441.30 and a 200-day moving average of GBX 4,306.92. The company has a debt-to-equity ratio of 62.17, a quick ratio of 0.80 and a current ratio of 2.17. The stock has a market cap of £6.61 billion, a price-to-earnings ratio of 56.97, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75.
Diploma (LON:DPLM - Get Free Report) last posted its earnings results on Wednesday, May 21st. The company reported GBX 80.20 ($1.10) earnings per share (EPS) for the quarter. Diploma had a return on equity of 13.18% and a net margin of 9.25%. On average, research analysts anticipate that Diploma PLC will post 163.7995512 earnings per share for the current year.
Insiders Place Their Bets
In other Diploma news, insider Katie Bickerstaffe acquired 39 shares of the company's stock in a transaction dated Tuesday, May 20th. The shares were acquired at an average price of GBX 4,981 ($68.35) per share, for a total transaction of £1,942.59 ($2,665.83). Insiders have purchased a total of 96 shares of company stock worth $473,173 in the last quarter. 0.52% of the stock is owned by company insiders.
Diploma Company Profile
(
Get Free Report)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Further Reading
Before you consider Diploma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.
While Diploma currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
